金吾财讯 | 据外媒报道,罗氏控股(RHHBY)未来五年将在美国投资500亿美元用于制药和诊断业务,相关计划包括扩大和升级肯塔基州、印第安纳州、新泽西州、俄勒冈州和加利福尼亚州的制造和分销能力。罗氏还计划建立一家生产工厂,以支持下一代减肥药的扩产,但没有透露工厂的位置。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.